Aviva's PIIGS Exposure is a Source of Concern

A deepening financial crisis in Europe could have a detrimental effect on Aviva's shareholders as well as customers

Jim Ryan 8 August, 2011 | 11:56AM
Facebook Twitter LinkedIn

Aviva (AV.) reported a first-half loss of £59 million, driven by adverse investment variance from Delta Lloyd (DL), which it partially sold during the first half. Excluding this charge, pretax operating profits were 29 pence per share, up 6% on a year-over-year basis. Of concern to us is the large sovereign bond exposure Aviva has to PIIGS countries. Although most of the exposure is in participating fund assets, about £8 billion, Aviva still has £1.6 billion of shareholder assets in Ireland, Spain, and Italy bonds, about 14% of book equity. A deepening financial crisis in Europe could have a detrimental effect on both shareholders and the firm's customers.

For the entire note and research report, click here.

Morningstar's Equity Analyst Notes and Equity Research Reports contain our independent view on a company's investment case, valuation, financial health and stewardship, and are available to Premium subscribers.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
Aviva PLC483.80 GBX0.90Rating

About Author

Jim Ryan  Jim Ryan is a senior analyst with Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures